Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter and half-year ended September 30, 2016
Filing Date: October 25, 2016
This filing serves as a disclosure of results of operations and financial condition. The company announced its results under International Financial Reporting Standards (IFRS) via a press release and made Unaudited Standalone and Consolidated Financial Results under Indian Accounting Standards (Ind AS) available on its website.
Key Financial Metrics
The provided filing text acts as a cover document referencing attached exhibits (99.1, 99.2, and 99.3) containing the detailed financial data. The text of this Form 6-K does not provide clear values for the following metrics:
- Revenue
- Profit (Net Income)
- Cash Flow
- Margins
- Debt Levels
- Liquidity Ratios
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached exhibits (Press Release and Ind AS Financial Results) for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not include specific management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. These details are contained within the referenced press release and financial statements attached as exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for IFRS-based revenue, profit, and margin figures.
- Examine Exhibit 99.2 and Exhibit 99.3 for Ind AS-based standalone and consolidated financial results.
- Verify the specific impact of currency fluctuations and regulatory changes mentioned in the full press release.
- Check the review reports attached to the Ind AS results for auditor qualifications or notes.